"Self-Compassion and Self-Efficacy in Parkinson's Disease: Associations With Symptoms, Function, and Quality of Life"
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Self-Report Questionnaire Assessment.
- Who it may be relevant to
- Registry conditions: Parkinson Disease, Physical Disability. Basic parameters: 40 years — 85 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Turkey (Türkiye)
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
"Associations of Self-Compassion and Self-Efficacy With Symptom Severity, Functional Status, and Quality of Life in Individuals With Parkinson's Disease: A Cross-Sectional Study"
Overview
The aim of this study is to evaluate the associations of self-compassion and self-efficacy levels with symptom severity, functional status, and quality of life in individuals with Parkinson's disease.
Interventions
- Other Self-Report Questionnaire Assessment
This study does not involve any therapeutic intervention. Participants will complete a set of self-report questionnaires assessing self-compassion, self-efficacy, symptom severity, functional status, and quality of life. Data will be collected in a single session for observational analysis.
Primary outcome measures
- Self-Compassion Scale (SCS) Total Score [Time frame: Baseline (at the time of questionnaire completion)]
- Self-Efficacy for Managing Chronic Disease 6-Item Scale Total Score [Time frame: Baseline (at the time of questionnaire completion)]
- Unified Parkinson's Disease Rating Scale (UPDRS) Total Score [Time frame: Baseline (at the time of questionnaire completion)]
Secondary outcome measures (4)
- Timed Up and Go (TUG) Test Completion Time in Seconds [Time frame: Baseline (at the time of questionnaire completion)]
- Six-Minute Walk Test (6MWT) Distance in Meters [Time frame: Baseline (at the time of questionnaire completion)]
- Mini-Balance Evaluation Systems Test (Mini-BESTest) Total Score [Time frame: Baseline (at the time of questionnaire completion)]
- Parkinson's Disease Questionnaire-39 (PDQ-39) Total Score [Time frame: Baseline (at the time of questionnaire completion)]
Eligibility criteria
Inclusion criteria
- Clinical diagnosis of Parkinson's disease
- Hoehn and Yahr stage 1-3
- Age 40 to 85 years
- Mini-Mental State Examination (MMSE) score ≥24
- Sufficient cognitive function to communicate and complete study assessments
- Attending the Movement Disorders Outpatient Clinic, Department of Neurology
- Able and willing to provide written informed consent
Exclusion criteria
- Major depressive disorder or psychotic disorder
- Advanced dementia
- Uncontrolled chronic systemic disease (e.g., diabetes mellitus or hypertension)
- Severe cardiovascular or respiratory disease
- Additional neurological or orthopedic conditions that may affect assessment performance
- Severe visual or hearing impairment that could interfere with study assessments
- Inability to cooperate with the physiotherapist during study assessments
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
Turkey (Türkiye) · 1 center
- Acibadem University — Istanbul
Identifiers
NCT: NCT07488351 · 2026-03-130